Health Care/Hospital News & Press Release Distribution

Harbour BioMed Announces Positive Profit Alert

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-01-19 12:52 4989

Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong

GUANGZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Infinitus kicked off 2024 with the 'Co-creating a New Future' annual conference held in Foshan,Guangdong on January 13, 2024. Family members of the Lee Kum Kee Group and Infinitus’ Central Management ...

2024-01-19 11:42 1740

Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong

Airai Global Corporation Officially Team Up with Airai State Government Palau Joint Developed Integrated Luxuries Tourism & Modern Wellness Transformation Program

Double Collaboration Agreement Signing Marks a Milestone at Sheraton Petaling Jaya Hotel KUALA LUMPUR, Malaysia, Jan. 19, 2024 /PRNewswire/ -- The Airai State Government welcomes Airai Global Corporation in a historic collaboration to revolutionize eco-tourism and healthcare inPalau. This transf...

2024-01-19 10:00 1761

Airai Global Corporation Officially Team Up with Airai State Government Palau Joint Developed Integrated Luxuries Tourism & Modern Wellness Transformation Program

Datasea Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

BEIJING, Jan. 18, 2024 /PRNewswire/ -- Datasea Inc., a Nevada corporation (NASDAQ: DTSS) ("Datasea" or the "Company"), which engages in the business segments of U.S.-based intelligent acoustics andChina-based 5G messaging technology, today announced that the Company's Board of Directors has appro...

2024-01-19 05:39 3565

Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance

SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...

2024-01-18 22:34 1789

Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance

SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...

2024-01-18 22:18 1817

PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia (...

2024-01-18 16:00 2210

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific

* Boehringer Ingelheim is recognized as one of 17 Top Employers worldwide and for the fifth consecutive year inAsia Pacific * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development...

2024-01-18 12:00 1485

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Thailand

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inThailand * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development BANGKO...

2024-01-18 12:00 1287

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Malaysia

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inMalaysia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development KUALA ...

2024-01-18 12:00 1299

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development JAK...

2024-01-18 12:00 1332

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

HIGHLIGHTS * The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in theUSA * The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in theUSA MELBOURNE, Australia ,Jan. ...

2024-01-18 10:31 1157

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

* Octapharma will present new clinical and scientific findings for wilate® and Nuwiq® * New findings in von Willebrand disease (VWD) and haemophilia A, will be presented by leading experts in a Satellite Symposium, as well as an oral and six poster presentations * Presentations will include...

2024-01-18 02:20 1603

Seal Storage Technology Bolsters Compliance with HIPAA-Compliant Blockchain-Based Data Storage

TORONTO, Jan. 17, 2024 /PRNewswire/ -- - Seal Storage Technology, a leading provider of blockchain-powered cloud storage, is now able to enter Business Associate Agreements (BAAs) to handle protected health information (PHI) with its completion of HIPAA certification. Seal's compliance with HIPAA...

2024-01-17 23:45 1335

Seno Medical Earns Frost & Sullivan's 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology

Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer and significantly reduce unnecessary breast biopsies. SAN ANTONIO, Jan. 17, 2024 /PRNewswire/ -- Frost & Sullivan recently recognizedSeno Medical with the 2023 US Enabling Technology Leadersh...

2024-01-17 23:00 1388

Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

- Lunit's AI-powered chest X-ray analysis solution shows highest AUC of 0.93 in a recent multi-center, multi-use case, multi-vendor lung nodule detection study SEOUL, South Korea, Jan. 17, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostic...

2024-01-17 22:15 1377

Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

Shaping International Economics and Ethical Dialogues Through the Leadership of Cheah Chyuan Yong

KUALA LUMPUR, Malaysia, Jan. 17, 2024 /PRNewswire/ -- Under the visionary leadership ofCheah Chyuan Yong, the International Strategy Institute (ISI) proudly declares the successful conclusion of two groundbreaking global conferences: the 12th World Chinese Economic Forum (WCEF) and the World Ant...

2024-01-17 21:41 1697

Shaping International Economics and Ethical Dialogues Through the Leadership of Cheah Chyuan Yong

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansionshowed clinical benefit including confirmed responses at higher, more frequent and repeat doses of the anti-CTLA-4 therapy - - Preliminary survival analysis of ADG126 10 mg/kg do...

2024-01-17 20:00 2381

Envision Energy Announces Collaboration with Five Global Healthcare Leaders to Unlock Renewable Energy in Davos

Envision Energy signed a three-year renewable energy supply agreement with AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche, to offer around 200 gigawatt-hours (GWh) of green power annually from 2024, resulting in annual carbon dioxide equivalent savings of approximately 120,000 tons. ...

2024-01-17 14:50 1587

Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National Comprehensive Cancer Network (NCCN)

SUZHOU, China, and ROCKVILLE, Md., Jan. 16, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that olverembatinib (R&D Code: HQP1351) has been ...

2024-01-17 12:10 3764